loadpatents
name:-0.032561063766479
name:-0.022621870040894
name:-0.0051298141479492
HAGIWARA; Masatoshi Patent Filings

HAGIWARA; Masatoshi

Patent Applications and Registrations

Patent applications and USPTO patent grants for HAGIWARA; Masatoshi.The latest application filed is for "vehicle control device and control method".

Company Profile
5.26.32
  • HAGIWARA; Masatoshi - Kobe-shi JP
  • Hagiwara; Masatoshi - Kyoto JP
  • Hagiwara; Masatoshi - Kobe JP
  • HAGIWARA; Masatoshi - Kyoto-shi Kyoto
  • Hagiwara; Masatoshi - Chiba N/A JP
  • Hagiwara; Masatoshi - Tokyo JP
  • Hagiwara; Masatoshi - Hyogo JP
  • Hagiwara; Masatoshi - Nagoya JP
  • Hagiwara; Masatoshi - Nogoya JP
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Vehicle Control Device And Control Method
App 20220227354 - HAGIWARA; Masatoshi
2022-07-21
Pharmaceutical Composition for Alzheimer's Disease
App 20220226341 - Hagiwara; Masatoshi ;   et al.
2022-07-21
Composition for activating neurogenesis
Grant 11,318,126 - Hagiwara , et al. May 3, 2
2022-05-03
Method for Suppressing Freezing Damage and Composition for Preventing Freezing Damage
App 20210204539 - Hagiwara; Masatoshi ;   et al.
2021-07-08
Pharmaceutical Composition And Treatment Method For Genetic Disease Associated With Splicing Abnormalities
App 20210205314 - Hagiwara; Masatoshi ;   et al.
2021-07-08
Tumor Suppression
App 20210100781 - HAGIWARA; Masatoshi ;   et al.
2021-04-08
Pharmaceutical Composition For Inducing Programmed Cell Death In Cancer Cells
App 20200188382 - HAGIWARA; Masatoshi ;   et al.
2020-06-18
Pharmaceutical Composition And Treatment Method For Genetic Disease Associated With Splicing Abnormalities
App 20200113907 - Hagiwara; Masatoshi ;   et al.
2020-04-16
Medicinal Composition Inhibiting Neovascularization Proliferation Factor
App 20190365762 - HAGIWARA; Masatoshi ;   et al.
2019-12-05
Composition For Activating Neurogenesis
App 20190247384 - HAGIWARA; Masatoshi ;   et al.
2019-08-15
Engine control device
Grant 10,281,446 - Hagiwara
2019-05-07
Composition Having Compound Accelerating Phosphorylation Of Ampk As Effective Component
App 20180290979 - HAGIWARA; Masatoshi ;   et al.
2018-10-11
Compound and pharmaceutical composition for neuropsychological disorder or malignant tumor
Grant 10,017,524 - Hagiwara , et al. July 10, 2
2018-07-10
Engine Control Device
App 20180136183 - HAGIWARA; Masatoshi
2018-05-17
Method for screening substance capable of inhibiting abnormal splicing causative of onset or progress of disease
Grant 9,879,014 - Hagiwara , et al. January 30, 2
2018-01-30
Compound And Pharmaceutical Composition For Neuropsychological Disorder Or Malignant Tumor
App 20170355715 - HAGIWARA; Masatoshi ;   et al.
2017-12-14
Compound and pharmaceutical composition for neuropsychological disorder or malignant tumor
Grant 9,745,323 - Hagiwara , et al. August 29, 2
2017-08-29
Pain-related compound and medical composition
Grant 9,745,275 - Hagiwara , et al. August 29, 2
2017-08-29
Medicinal Composition Inhibiting Neovascularization Proliferation Factor
App 20170128449 - HAGIWARA; Masatoshi ;   et al.
2017-05-11
Pain-related Compound And Medical Composition
App 20170029389 - HAGIWARA; Masatoshi ;   et al.
2017-02-02
Compound Pertaining To Neuropoiesis And Drug Composition
App 20160303089 - HAGIWARA; Masatoshi ;   et al.
2016-10-20
Method For Screening Substance Capable Of Inhibiting Abnormal Splicing Causative Of Onset Or Progress Of Disease
App 20160152620 - HAGIWARA; Masatoshi ;   et al.
2016-06-02
Transgenic reporter system that reveals expression profiles and regulation mechanisms of alternative splicing in mammalian organisms
Grant 9,273,364 - Hagiwara , et al. March 1, 2
2016-03-01
Prophylactic or ameliorating agent for genetic diseases
Grant 9,241,929 - Hagiwara , et al. January 26, 2
2016-01-26
Compound And Pharmaceutical Composition For Neuropsychological Disorder Or Malignant Tumor
App 20150225421 - Hagiwara; Masatoshi ;   et al.
2015-08-13
Screening Method, Protein Instability And/or Stability Inducers, And Protein Activity Assessment
App 20150133467 - Hagiwara; Masatoshi ;   et al.
2015-05-14
Methods for controlling SR protein phosphorylation, and antiviral agents whose active ingredients comprise agents that control SR protein activity
Grant 8,816,089 - Hagiwara , et al. August 26, 2
2014-08-26
Aniline derivative having anti-RNA viral activity
Grant 8,765,941 - Onogi , et al. July 1, 2
2014-07-01
Transgenic Reporter System That Reveals Expression Profiles And Regulation Mechanisms Of Alternative Splicing In Mammalian Organisms
App 20130137099 - Hagiwara; Masatoshi ;   et al.
2013-05-30
Prophylactic or Ameliorating Agent for Genetic Diseases
App 20130102644 - Hagiwara; Masatoshi ;   et al.
2013-04-25
Methods For Controlling Sr Protein Phosphorylation, And Antiviral Agents Whose Active Ingredients Comprise Agents That Control Sr Protein Activity
App 20130079369 - Hagiwara; Masatoshi ;   et al.
2013-03-28
Methods for controlling SR protein phosphorylation, and antiviral agents whose active ingredients comprise agents that control SR protein activity
Grant 8,338,362 - Hagiwara , et al. December 25, 2
2012-12-25
Transgenic reporter system that reveals expression profiles and regulation mechanisms of alternative splicing in nematodes
Grant 7,928,283 - Kuroyanagi , et al. April 19, 2
2011-04-19
Aniline Derivative Having Anti-rna Viral Activity
App 20110059950 - Onogi; Hiroshi ;   et al.
2011-03-10
Therapeutic composition of treating abnormal splicing caused by the excessive kinase induction
Grant 7,786,151 - Hagiwara , et al. August 31, 2
2010-08-31
Vehicular electronic control apparatus and method for controlling vehicle
Grant 7,739,013 - Ishio , et al. June 15, 2
2010-06-15
Methods For Controlling Sr Protein Phosphorylation, And Antiviral Agents Whose Active Ingredients Comprise Agents That Control Sr Protein Activity
App 20100016359 - Hagiwara; Masatoshi ;   et al.
2010-01-21
Method for controlling SR protein phosphorylation, and antiviral agents whose active ingredients comprise agents that control SR protein activity
Grant 7,569,536 - Hagiwara , et al. August 4, 2
2009-08-04
Transgenic reporter system that reveals expression profiles and regulation mechanisms of alternative splicing in living organisms
App 20080095712 - Kuroyanagi; Hidehito ;   et al.
2008-04-24
Vehicle controller and vehicle control method
Grant 7,280,908 - Maehara , et al. October 9, 2
2007-10-09
Method for controlling sr protein phosphorylation, and antiviral agents whose active ingredients comprise agents that control sr protein activity
App 20070135367 - Hagiwara; Masatoshi ;   et al.
2007-06-14
Vehicular electronic control apparatus and method for controlling vehicle
App 20060122752 - Ishio; Masato ;   et al.
2006-06-08
Vehicle controller and vehicle control method
App 20050225175 - Maehara, Hiroaki ;   et al.
2005-10-13
Therapeutic composition of treating abnormal splicing caused by the excessive kinase induction
App 20050171026 - Hagiwara, Masatoshi ;   et al.
2005-08-04
Compound having vessel smooth muscle relaxation activity
Grant 5,245,034 - Hidaka , et al. September 14, 1
1993-09-14
Derivatives of isoquinoline (and naphthalene) sulfonamides
Grant 5,216,150 - Hidaka , et al. June 1, 1
1993-06-01
Compound having vessel smooth muscle relaxation activity
Grant 5,081,246 - Hidaka , et al. January 14, 1
1992-01-14

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed